1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
ROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024045 Therapeutics (Sprout IX, formerly NASDAQ: RNAI, exited through sale to Merck, 8.1x multiple). e Structured Investments in Public Companies: The Fund Managers have led and participated in a number of structured investments into small cap public companies. These have inclu
No connected entities